— Guides
BPC-157: What It Is and How It Is Researched
September 12, 2026

BPC-157 is by far the most studied peptide in tissue-repair models. It is also one of the most misunderstood: a lot of circulating information confuses what has been observed in rats with what is known in humans. This guide separates one from the other.
What BPC-157 is
BPC stands for Body Protection Compound. It is a pentadecapeptide — fifteen amino acids — whose sequence was isolated from a protective protein present in human gastric juice.
That origin explains its most-cited trait in the literature: unlike most peptides, BPC-157 remains stable in an acidic medium. Peptides usually degrade quickly in the digestive tract; this one withstands it, because it evolved precisely in that environment.
What the research says
The body of literature is broad and covers several lines:
- Connective tissue. The best-documented line: studies on tendon, ligament and muscle repair in induced-injury models.
- Angiogenesis. Work describing its relationship with the formation of new blood vessels, a central process in any repair.
- Gastrointestinal tract. Research on mucosal integrity and the response to damaging agents.
- Nitric-oxide pathway. Several studies link it to NO signalling, which could explain part of the vascular effects observed.
The caveat almost nobody mentions
Here is the uncomfortable and necessary part: practically all of that evidence comes from animal models, mostly rodents. Human clinical trials with BPC-157 are extremely scarce and very limited in scope.
That does not invalidate the research — it is exactly the phase the compound is in — but it does oblige you to read any categorical claim carefully. A result in a rat is a hypothesis about humans, not a conclusion. Whoever sells it to you as something proven is not informing you properly.
Regulatory status
BPC-157 is not approved as a medicine in any country and has no INVIMA health registration in Colombia. It is sold exclusively as research material.
One more point worth knowing: the World Anti-Doping Agency (WADA) included it on its Prohibited List. If you are a registered athlete or compete under anti-doping control, bear that in mind.
Available vial sizes
At Peptigene we stock it on its own and within three combined formulations:
- BPC-157 10 mg — the isolated compound, for protocols that want to study its effect separately.
- TB4 Blend + BPC-157 in 5 mg + 5 mg and in 10 mg + 10 mg.
- Glow 70 mg — with GHK-Cu and TB-500.
- Klow 80 mg — the previous one plus KPV.
On its own or in a blend
It is the most frequent practical decision. It depends on what you want to answer:
| BPC-157 alone | In a blend | |
|---|---|---|
| Attribution | You know what produced what | You cannot isolate the effect |
| Cost | Higher if you add compounds | Lower than buying them separately |
| Handling | One vial per compound | A single vial |
| Ratios | You define them | Fixed at the factory |
If the aim is to understand the mechanism, the isolated compound. If it is to cover several repair pathways at once, the blend.
How to judge quality
- Purity above 99% determined by HPLC and confirmed by mass spectrometry.
- Traceable batch number with its corresponding analysis. Ask for it: if they cannot give it to you, no verification is possible.
- White, homogeneous lyophilised powder. Yellowish, damp or sticky means storage failed.
- Intact seal and unpunctured stopper.
Storage
Lyophilised and unopened: refrigeration at 2–8 °C protected from light, or frozen for long periods. Reconstituted: constant refrigeration and stability reduced to weeks, not months.
Avoid repeated freeze–thaw cycles. Our reconstitution guide details the procedure and the errors that degrade the compound.
Frequently asked questions
Is it absorbed orally?
Its stability in an acidic medium is a documented fact, and that is where the idea comes from. But stability is not absorption: that a molecule survives the stomach does not mean it crosses the intestinal barrier in a relevant amount. It is an open question in the literature, and in any case this material is not intended for human consumption.
What is the difference between BPC-157 and TB-500?
They act on different pathways of the same process. BPC-157 is associated with angiogenesis and connective tissue; TB-500 with actin regulation and cell migration. That is why they often appear combined.
Are the 10 mg per vial?
Yes, each vial contains 10 mg of lyophilised compound. In the blends the label states the amount of each component separately.
Do you ship nationwide and abroad?
Yes. We dispatch from Medellín to all of Colombia with discreet packaging and a tracking number, and we also ship to the United States and Spain. Delivery times are on the shipping and returns page.
Notice. This article is for information only and concerns compounds intended for scientific research and laboratory development. It is not medical advice and not a recommendation for use in humans. BPC-157 has no INVIMA health registration, is not approved as a medicine in any country and appears on the WADA Prohibited List. Always consult a qualified healthcare professional before making any decision about your health.